Perkinelmer health sciences INC:1106024 [16-003789]acquisition of T histone demethylases (KDM5A/KDM5B) kits for ongoing project work. For ajit jadhav/S.kales
Ended Awarded
- Contract number
- HHSN31900001
- Awardee
-
Revvity Health Sciences, Inc. UEI G2TETZJTELL4 Part of Revvity Inc.
- Awarding agency
-
National Center for Advancing Translational Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $22,206
Award facts
- Contract value 100% obligated
- $22,206.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6810 Chemicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Shelton, CT 06484, USA
Award details come from SAM.gov/FPDS.
About this award
On April 27, 2016, the National Center for Advancing Translational Sciences awarded a $22,206 firm fixed-price Blanket Purchase Agreement (BPA) call to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) for the acquisition of histone demethylases (KDM5A/KDM5B) kits to support ongoing project work for researchers Ajit Jadhav and S. Kales. The contract was completed by March 31, 2017, and performed at the contractor's facility in Shelton, Connecticut. No small business set-aside was utilized for this award.
As a large business contractor specializing in medical imaging products, laboratory equipment, and scientific instrumentation, Revvity Health Sciences provides a comprehensive range of research-supporting technologies and supplies to federal civilian agencies. The histone demethylase kits procured under this award support the National Center for Advancing Translational Sciences' mission to accelerate the translation of laboratory discoveries into practical applications and clinical treatments. This contract represents typical procurement activity within Revvity's extensive federal portfolio, which includes specialized scientific equipment, reagents, and supplies serving research institutions and agencies including the National Institutes of Health and Centers for Disease Control and Prevention.
Quick answers
Who was awarded contract HHSN31900001?
HHSN31900001 was awarded to Revvity Health Sciences, Inc. by National Center for Advancing Translational Sciences (National Institutes of Health) on April 27, 2016.
How much is contract HHSN31900001 worth?
The government has obligated $22,206 on HHSN31900001.
Is contract HHSN31900001 an order under another contract?
Yes. HHSN31900001 is a BPA call under HHSN263201500062B, a blanket purchase agreement.
Was contract HHSN31900001 competed?
The extent of competition for HHSN31900001 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award